These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 20148658)

  • 1. Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy.
    Ma IH; Hsia Y; Hsieh YT; Ho TC; Lai TT; Yang CM; Yang CH
    Sci Rep; 2021 Oct; 11(1):20115. PubMed ID: 34635762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic steroids for the management of choroidal neovascular membrane with pigment epithelial tear and recalcitrant subretinal fluid.
    Bilgic A; Sudhalkar A
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31494592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypoidal choroidal vasculopathy: An update on current management and review of literature.
    Palkar AH; Khetan V
    Taiwan J Ophthalmol; 2019; 9(2):72-92. PubMed ID: 31198666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypoidal Choroidal Vasculopathy.
    Goldhardt R; Rosen BS
    Curr Ophthalmol Rep; 2019 Mar; 7(1):66-72. PubMed ID: 30976461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypoidal choroidal vasculopathy: a comprehensive clinical update.
    Kumar A; Kumawat D; Sundar M D; Gagrani M; Gupta B; Roop P; Hasan N; Sharma A; Chawla R
    Ther Adv Ophthalmol; 2019; 11():2515841419831152. PubMed ID: 30834360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Kumar A; Mutha V; Sundar DM
    Indian J Ophthalmol; 2018 Aug; 66(8):1128-1129. PubMed ID: 30038156
    [No Abstract]   [Full Text] [Related]  

  • 7. Polypoidal Choroidal Vasculopathy.
    Kim JB; Nirwan RS; Kuriyan AE
    Curr Ophthalmol Rep; 2017 Jun; 5(2):176-186. PubMed ID: 29276655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy.
    Sakai T; Kato N; Kubota M; Tsuneoka H
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1565-1571. PubMed ID: 28601912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic steroids as an aid to the management of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV): A descriptive analysis.
    Sudhalkar A; Balakrishnan D; Jalali S; Narayanan R
    Saudi J Ophthalmol; 2016; 30(1):14-9. PubMed ID: 26949352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysis.
    Tang K; Si JK; Guo DD; Cui Y; Du YX; Pan XM; Bi HS
    Int J Ophthalmol; 2015; 8(5):1056-66. PubMed ID: 26558226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypoidal choroidal vasculopathy: an update on therapeutic approaches.
    Wong RL; Lai TY
    J Ophthalmic Vis Res; 2013 Oct; 8(4):359-71. PubMed ID: 24653824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year outcome of photodynamic therapy combined with intravitreal injection of bevacizumab and triamcinolone acetonide for polypoidal choroidal vasculopathy.
    Nakata I; Tsujikawa A; Yamashiro K; Otani A; Ooto S; Akagi-Kurashige Y; Ueda-Arakawa N; Iwama D; Yoshimura N
    Graefes Arch Clin Exp Ophthalmol; 2013 Apr; 251(4):1073-80. PubMed ID: 22923282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
    Chan WM; Lai TY; Wong AL; Tong JP; Liu DT; Lam DS
    Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
    Chan WM; Lai TY; Wong AL; Liu DT; Lam DS
    Br J Ophthalmol; 2007 Feb; 91(2):174-9. PubMed ID: 16987898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series.
    Chan WM; Lai TY; Lau TT; Lee VY; Liu DT; Lam DS
    Retina; 2008 Jan; 28(1):71-80. PubMed ID: 18185141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy.
    Lai TY; Lam CP; Luk FO; Chan RP; Chan WM; Liu DT; Lam DS
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):91-5. PubMed ID: 20148658
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.